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Abstract
Objectives: To verify the frequency of oral and facial involvement in diagnosed leprosy patients. 
Study design: This study was performed on 100 leprosy patients (62 male, 38 female, mean ages 51.86±6.1). After 
explaining the study design, we studied descriptive information including: patient’s sex, age, job, place of birth, 
familial history of leprosy, types of disease (lepromatous, borderline and tuberculoid leprosy), ocular and oral le-
sions, facial involvement and neuropathy. The statistical signification was measured by chi-square test. 
Results: A total of 46 (23 lepromatous, 15 borderline, and 8 tuberculoid leproy) out of 100 patients with leprosy 
had oral lesions. Statistical analysis did not show any significant difference in frequency of oral lesions between 
different types of disease. Facial lesions were presented in 57 (39 lepromatous, 10 borderline, and 8 tuberculoid 
leprosy) patients. There was a statistical significant difference in frequency of facial manifestations between dif-
ferent types of leprosy. It has to be mentioned that, atrophy of nasal spine, facial nerve involvement, ocular lesions 
and facial deformity were seen in 15%, 17%, 22% and 44% of leprosy patients, respectively. 
Conclusion: Examination of leprosy patients should be extended to the oral mucosa because oral mucosa may be 
a secondary source of M.Leprae transmission and infection.
Key words: Leprosy, lepromatous, tuberculoid, oral lesions, facial lesions.      
Taheri JB, Mortazavi H, Moshfeghi M, Bakhshi M, Bakhtiari S, Azari-Marha-
bi S, Alirezaei S. Oro-facial manifestations of 100 leprosy patients. Med Oral 
Patol Oral Cir Bucal. 2012 Sep 1;17 (5):e728-32. 
http://www.medicinaoral.com/medoralfree01/v17i5/medoralv17i5p728.pdf
Article Number: 17718          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
doi:10.4317/medoral.17718
http://dx.doi.org/doi:10.4317/medoral.17718
Med Oral Patol Oral Cir Bucal. 2012 Sep 1;17 (5):e728-32.                                                                                                                                                             Oro-facial manifestations of leprosy
e729
Introduction
Leprosy is a chronic infectious contagious disease pro-
duced by Mycobacterium Leprae (M. Leprae). It mainly 
affects the skin and peripheral nerves. Involvement of 
internal organs and mucosa has been also reported (1,2). 
Leprosy is still a public health problem in many areas of 
the world; over than 80% of all reported cases are noted 
in seven countries: Brazil, India, Indonesia, Madagascar, 
Myanmar, Nepal and Nigeria (3- 5). 
Clinical presentations of leprosy are related to the im-
mune response against M. Leprae. The first, tuberculoid 
leprosy (paucibacillary; TT) that is characterized by high 
immune reaction to the organism, a few cutaneous lesions 
and little number of bacilli in skin biopsy specimens. The 
second, lepromatous leprosy (multibacillary; LL), that 
usually develops in patients with reduced cell-mediated 
response and negative lepromin skin tests (2,6,7). Within 
this spectrum there are borderline and less common varia-
tions with intermediate lesions. The main clinical features 
of leprosy are listed as follows: erythematous or hypo-
pigmented macules on the skin with reduced sensation, 
distinct sensory loss and peripheral nerve involvements, 
muscle weakness, nerve thickening, positive skin biopsy 
of acid – fast bacilli and positive skin smear. It is noted 
that a subject with one or two of these major findings 
should be considered as a leprosy case (8). 
Oral lesions are rare in this disease but when present 
occur in lepromatous form (6,9). These lesions initially 
appears as yellowish to red, sessile, firm, papule or nod-
ules that develop ulceration and necrosis. Continuous in-
fection can lead to scarring and tissue destruction (3,6). 
Unfortunately, in contrast to cutaneous manifestations 
of leprosy that are well discussed in medical literature, 
there are few studies around the oral findings in leprosy 
patients (2,10). Recently, it has been suggested that oral 
mucosa may be a secondary source of M. Leprae infec-
tion and transmission (1). 
Also, it is noted that there is an association between the 
recurrence of leprosy reactional episodes and oral mani-
festations in leprosy patients (11). For these reasons, oral 
examinations should be done in these patients. 
Material and Methods 
This study was performed at the Shahid Bolandian 
Health center of Qazvin, Iran. A hundred leprosy pa-
tients (62 male, 38 female, mean ages 51.86±6.1) were 
selected. After explaining the study design, written in-
formed consent was obtained from all participants. Then 
we studied descriptive information including: patient’s 
sex, age, job, place of birth, familial history of leprosy, 
types of disease (lepromatous, borderline and tubercu-
loid leprosy), ocular and oral lesions, facial deformities 
and neuropathy. Previous treatment was an exclusion 
criterion in present report. The data analysis was done 
using SPSS version 13 for windows and the statistical 
signification was measured by chi-square test. P-value 
less than 0.05 (p<0.05) were considered as statistically 
significant.
Results 
Among 100 leprosy patients, 62 (62%) were male and 38 
(38%) were female, with ages ranging from 7 to 87 years. 
However, most of the patients (77%) were between 30 
and 70 years old (Table 1). More than half of the subjects 
Table 1. Partakers’ self-assessment of their capacities to undertake a SFE (Likert 1-5 scale).
LL: Lepromatous Leprosy; TT: Tuberculoid Leprosy; BB: Borderline Leprosy; I: Indeterminate
Leprosy Patients LL (n :%) TT (n :%) BB (n :%) I (n :%) Total
Sex 
Male (25: 25%) (16: 16%) (19: 19%) (2: 20%) (62: 62%)
Female (21: 21%) (3: 3%) (14: 14%) (-: -) (38: 38%)
Total (46: 46%) (19: 19%) (33: 33%) (-: -) (100: 100%)
Age
<30 years (3: 3%) (3: 3%) (3: 3%) (2: 2%) (11: 11%)
30-60 years (17: 17%) (5: 5%) (18: 18%) (-: -) (40: 40%)
> 60 years (26: 26%) (11: 11%) (12: 12%) (-: -) (49: 49%)
Total (46: 46%) (19: 19%) (33: 33%) (-: -) (100: 100%)
Familial history (22: 37%) (11: 19%) (24: 41%) (2: 3%) (59: 59%)
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(61%) were farmer and about 40% of them were born in 
Gylan province, city of Rudbar, North of Iran. 
The different types of disease in this study were: 2 (2%) 
indeterminate, 33 (33%) border line, 46 (46%) lepromatous 
and 19 (19%) tuberculoid leprosy.
Familial history of leprosy was observed in 59 (59%) cases 
(Table 1). Most of the patients had their leprosy diagnosed 
8 months after the first signs and symptoms appeared. 
A total of 46 (23 lepromatous, 15 borderline, and 8 tu-
berculoid leproy) out of 100 patients with leprosy had 
oral lesions. 
Statistical analysis did not show any significant differ-
ence in frequency of oral lesions between different types 
of disease (p=0.390).
In this study, facial lesions were presented in 57 (39 
lepromatous, 10 borderline, and 8 tuberculoid leprosy) 
patients. Obviously, there was a statistical significant 
difference in frequency of facial manifestations between 
different types of leprosy (p=0.002). It has to be men-
tioned that, atrophy of nasal spine, facial nerve involve-
ment, ocular lesions (Lagophthalmous, keratitis, and 
conjunctivitis) and facial deformity were seen in 15%, 
17%, 22% and 44% of leprosy patients, respectively. 
Oro-facial manifestations of leprosy in different types of 
disease were summarized in table 2. 
Table 2. Distribution of Oro-facial lesions in 100 Leprosy patients.
LL: Lepromatous Leprosy; TT: Tuberculoid Leprosy; BB: Borderline Leprosy; I: Indeterminate.
Discussion 
The upper airways are the most important point of entry 
for bacillus and a main source for bacillary elimination 
in leprosy (6,12). In recent studies, oral mucosa seems to 
be the secondary (after nasal mucosa) site of M. Leprae 
infection and transmission (1,2). Also, involvement of 
oral mucosa may have a key role in leprosy transmission 
from adults to children (13). Indeed, it is established that 
these lesions tended to be more frequent over the first 5 
years of the disease (3,10). 
For these reasons, evaluation of oral cavity should be 
routine for leprosy patients (2,6). 
In this present study we evaluated 100 leprosy patients, 
the age of them ranged from 7 to 87 years, with average 
of 51.86±6.1. The number of male subjects (62: 62%) 
was higher than females (38:38%). 
This finding is in agreement with de Abreu et al.(2) and 
Boggild et al.(13). In contrast to this result, Souza et 
al.(10) did not show any difference between men and 
women in leprosy. 
The mean age of our leprosy patients was close to pre-
vious studies such as de Abreu et al.(2) and Souza et 
al.(10). In this study the rate of lepromatous leprosy was 
higher than other types of disease and it was more com-
mon in males than females. These findings are in accord-
ance to Boggild et al.(13) and Toweir et al.(14).
 In our study, familial history of leprosy was reported by 
59% of patients which most of them (41%) had border-
line leprosy. Also, the number of patients with familial 
history of lepromatous leprosy was higher than tuber-
culoid leprosy.  This finding may be related to the close 
contact with carriers of the bacillary (10). 
According to our results, oral involvement was observed 
in 46% of all studied cases (Figs. 1-3). It was more fre-
quently in patients with lepromatous leprosy. Unfortu-
Affected sites LL (n :%) TT (n :%) BB (n :%) I (n :%) Total
Uvula (7: 70%) (1: 10%) (2: 20%) - (10: 10%)
Tonsil (6: 75%) (-: -) (2: 25%) - (8: 8%)
Tongue (anterior two-third) (5: 42%) (5: 42%) (2: 16%) - (12: 12%)
Tongue (posterior one- third ) (7: 50%) (4: 29%) (3: 21%) - (14: 14%)
Soft palate  (11: 79%) (-: -) (3: 21%) - (14: 14%)
Hard palate (5: 83%) (-: -) (1: 17%) - (6: 6%)
Lips & gingival (6: 55%) (1: 9%) (4: 36%) - (11: 11%)
Atrophy of anterior maxillary 
alveolar ridge 
(8: 50%) (3: 19%) (5: 31%) - (16: 16%)
Facial deformity (38: 86%) (1: 3%) (5: 11%) - (44: 44%)
Atrophy of nasal spine (14: 93%) (-: -) (1: 7%) - (15: 15%)
Facial nerve involvement (7: 41%) (7: 41%) (3: 18%) - (17: 17%)
Ocular involvement (13: 59%) (5: 23%) (4: 18%) - (22: 22%)
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Fig. 1. Oral lesion involving the tongue in tuberculoid leprosy.
Fig. 2. Tumor like lesion in lepromatous leprosy patient.
Fig. 3. Oral lesion involving the palate in lepromatous leprosy.
nately, review of literature showed a discrepancy in fre-
quency rates of oral involvement in leprosy. For exam-
ple, oral lesions in leprosy patients have been reported 
from absent up to 57.5% (2,15,16).
On the other hand, Prabhu et al.(17), in an excellent re-
view of 700 leprosy patients showed that the prevalence 
of oral involvement in leprosy was 11.5% and also these 
lesions tended to occur in lepromatous leprosy. Some 
authors such as Motta et al.(6), Soni (18) and Palaskar 
(19) established that the oral lesions usually appear in 
the advanced stage of leprosy. 
In contrast to this hypothesis, de Abreu et al.(2), Brasil 
et al.(20) and Sharma et al.(21) demonstrated that oral 
lesions may occur in less advanced stages of the disease 
and also in these patients oral cavity involvement re-
mains clinically hidden (absence of visible lesions) and 
may only detected histopatholosically. This can be one 
of the main explanations for different rates of oral in-
volvement in leprosy seen in literature (2). 
It is suggested that oral involvement in leprosy occurs 
by hematogenous or lymphatic dissemination of M. Le-
prae (6,22). 
On the other hand, Bucci et al.(23) and Girdhar et al.(24) 
pointed out that nasal lesions may be precursors of oral 
lesions. 
In our study, of 46 patients with oral lesions, 8 had tuber-
culoid leprosy. Oral involvement in this type of disease 
is rare and it may be related to the intense response of the 
host’s immune system and little number of organisms in 
this type of disease (8). This finding is in disagreement 
with de Abreu et al. (25). 
de Abreu et al.(25), demonstrated that paucibacillary 
leprosy patients do not exhibit clinical or subclinical, 
involvement in the oral cavity. The distribution of oral 
lesions in our study are ranked as follows: soft palate, 
tongue (posterior one – third), tongue (anterior two 
–third), lips, uvula, tonsil, hard palate (Table 2). Accord-
ing to WHO, the most affected sites of oral cavity in 
leprosy patients are: hard palate, soft palate, labial max-
illary gingival and buccal mucosa (26). In this present 
report, involvement of tonsil, soft palate and hard palate 
was not observed in patients with tuberculoid leprosy.
Similar to our finding, Motta et al.(6), Brasil et al.(20) 
and Reichart (27) showed that the soft palate was af-
fected most frequently in almost all cases of leprosy. 
In this present study facial involvement was observed in 
39 (39 %) leprosy patients. This rate was 28% in Prab-
hu’s study (17). The frequency and distribution of facial 
involvements have been summarized in table 2. 
According to our findings, atrophy of nasal spine was 
not found in patients with tuberculoid leprosy. Also, 
ocular involvement was higher in lepromatous leprosy 
than other types of disease. Furthermore, the rate of fa-
cial nerve involvement was equal in lepromatous and 
tuberculoid leprosy.
Med Oral Patol Oral Cir Bucal. 2012 Sep 1;17 (5):e728-32.                                                                                                                                                            Oro-facial manifestations of leprosy
e732
In conclusion, examination of leprosy patients should be 
extended to the oral mucosa because oral mucosa may be a 
secondary source of M.leprae transmission and infection. 
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